I agree, Mt Cattlin definitely has the potential to bring in revenue in the short to mid term, we just need current prices to improve a little. If Mt Cattlin can't maintain economic viability in the short term (note - I think it will), even as the second lowest cost Australian producer, then god help the other Australian spodumene producers (with the exception of Talison). It appears that GXY is doing everything possible to keep costs as low as possible through 2020, which sets us up well for when demand does improve.
I'm not sure if it has been posted here already, but BMI's forecast of spod pricing is as follows:
Hopefully BMI is being conservative in their estimate. I'm hoping that the building demand will push the spod price higher, sooner.
GXY Price at posting:
$1.19 Sentiment: Buy Disclosure: Held